Fearing Chinese retaliatory tariffs and the ensuing price hikes, medical device manufacturers urged U.S. States Trade Representative (USTR) Robert Lighthizer to remove medical devices and technology from a proposed list of goods for which an additional 25 percent tariff would be imposed. The manufacturers argued that a trade war over devices would increase the regulatory burden by requiring companies request FDA approval of new suppliers of components and raw materials; hurt companies’ profit margins; undermine the American medical technology industry;...